These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 19562803)

  • 41. Differential nuclear proteomes in response to N-methyl-N'-nitro-N-nitrosoguanidine exposure.
    Shen J; Zhu H; Xiang X; Yu Y
    J Proteome Res; 2009 Jun; 8(6):2863-72. PubMed ID: 19364130
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Levels of neuregulin 1 and 3 proteins in Brodmann's area 46 from subjects with schizophrenia and bipolar disorder.
    Boer S; Berk M; Dean B
    Neurosci Lett; 2009 Nov; 466(1):27-9. PubMed ID: 19765633
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunoreactivity of 43 kDa growth-associated protein is decreased in post mortem hippocampus of bipolar disorder and schizophrenia.
    Tian SY; Wang JF; Bezchlibnyk YB; Young LT
    Neurosci Lett; 2007 Jan; 411(2):123-7. PubMed ID: 17095155
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Trypsin digest coupled with two-dimensional shotgun proteomics reveals the involvement of multiple signaling pathways in functional remodeling of late-gestation uteri in rats.
    Chen GY; Chen SH; Yu CH; Huang SY; Tsai ML
    Proteomics; 2008 Aug; 8(15):3173-84. PubMed ID: 18654981
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differential protein expression in the corpus callosum (genu) of human alcoholics.
    Kashem MA; Harper C; Matsumoto I
    Neurochem Int; 2008 Jul; 53(1-2):1-11. PubMed ID: 18513832
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A mouse model of anxiety molecularly characterized by altered protein networks in the brain proteome.
    Szego EM; Janáky T; Szabó Z; Csorba A; Kompagne H; Müller G; Lévay G; Simor A; Juhász G; Kékesi KA
    Eur Neuropsychopharmacol; 2010 Feb; 20(2):96-111. PubMed ID: 20015620
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Alterations in kynurenine precursor and product levels in schizophrenia and bipolar disorder.
    Miller CL; Llenos IC; Cwik M; Walkup J; Weis S
    Neurochem Int; 2008 May; 52(6):1297-303. PubMed ID: 18328600
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Development and plasticity-related changes in protein expression patterns in cat visual cortex: a fluorescent two-dimensional difference gel electrophoresis approach.
    Van den Bergh G; Clerens S; Firestein BL; Burnat K; Arckens L
    Proteomics; 2006 Jul; 6(13):3821-32. PubMed ID: 16739136
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vesicular glutamate transporter mRNA expression in the medial temporal lobe in major depressive disorder, bipolar disorder, and schizophrenia.
    Uezato A; Meador-Woodruff JH; McCullumsmith RE
    Bipolar Disord; 2009 Nov; 11(7):711-25. PubMed ID: 19839996
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gating deficits in isolation-reared rats are correlated with alterations in protein expression in nucleus accumbens.
    Roncada P; Bortolato M; Frau R; Saba P; Flore G; Soggiu A; Pisanu S; Amoresano A; Carpentieri A; Devoto P
    J Neurochem; 2009 Feb; 108(3):611-20. PubMed ID: 19054277
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The leukocytes expressing DARPP-32 are reduced in patients with schizophrenia and bipolar disorder.
    Torres KC; Souza BR; Miranda DM; Nicolato R; Neves FS; Barros AG; Dutra WO; Gollob KJ; Correa H; Romano-Silva MA
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):214-9. PubMed ID: 19059449
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differential changes in apolipoprotein E in schizophrenia and bipolar I disorder.
    Digney A; Keriakous D; Scarr E; Thomas E; Dean B
    Biol Psychiatry; 2005 Apr; 57(7):711-5. PubMed ID: 15820227
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anterior hippocampus in schizophrenia pathogenesis: molecular evidence from a proteome study.
    Nesvaderani M; Matsumoto I; Sivagnanasundaram S
    Aust N Z J Psychiatry; 2009 Apr; 43(4):310-22. PubMed ID: 19296286
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular determinants of dysregulated GABAergic gene expression in the prefrontal cortex of subjects with schizophrenia.
    Mellios N; Huang HS; Baker SP; Galdzicka M; Ginns E; Akbarian S
    Biol Psychiatry; 2009 Jun; 65(12):1006-14. PubMed ID: 19121517
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prominent synaptic and metabolic abnormalities revealed by proteomic analysis of the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder.
    Pennington K; Beasley CL; Dicker P; Fagan A; English J; Pariante CM; Wait R; Dunn MJ; Cotter DR
    Mol Psychiatry; 2008 Dec; 13(12):1102-17. PubMed ID: 17938637
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An organelle proteomic method to study neurotransmission-related proteins, applied to a neurodevelopmental model of schizophrenia.
    Vercauteren FG; Flores G; Ma W; Chabot JG; Geenen L; Clerens S; Fazel A; Bergeron JJ; Srivastava LK; Arckens L; Quirion R
    Proteomics; 2007 Oct; 7(19):3569-79. PubMed ID: 17907268
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Investigation of the expression of genes affecting cytomatrix active zone function in the amygdala in schizophrenia: effects of antipsychotic drugs.
    Weidenhofer J; Scott RJ; Tooney PA
    J Psychiatr Res; 2009 Jan; 43(3):282-90. PubMed ID: 18490030
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Developmental brain protein level changes in the C57BL/6J mouse.
    Myung JK; Shim KS; Li L; Höger H; Lubec G
    J Proteome Res; 2009 Mar; 8(3):1207-19. PubMed ID: 19154180
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identifying candidate serum biomarkers of exposure to tunicamycins in rats using two-dimensional electrophoresis.
    Penno MA; Bacic A; Colegate SM; Hoffmann P; Michalski WP
    J Proteome Res; 2009 Jun; 8(6):2812-26. PubMed ID: 19317491
    [TBL] [Abstract][Full Text] [Related]  

  • 60. N-Ethylmaleimide sensitive factor in the cortex of subjects with schizophrenia and bipolar I disorder.
    Gray L; Scarr E; Dean B
    Neurosci Lett; 2006 Jan; 391(3):112-5. PubMed ID: 16165270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.